Daily FNArena News - Australia

Domestically, NAB’s interim result was in line with peers. A lack of similar capital management nevertheless reflects the bank’s legacy UK albatross.

Weekly update on recommendation, target price, and earnings forecast changes.

Brokers were not ascribing value to Alzheimer’s treatment potential anyway, so Baxter’s disappointing trial does not impact on analysts’ CSL recommendations.

A wrap of the day’s activity on the Australian stock market.

Coca Cola Amatil’s decidedly downbeat AGM this week has analysts at odds over the once reliable strength of the Coke brand.

The latest auction of 4G spectrum procured a new bidder, TPG Telecom. Surprised brokers are now speculating as to just what TPG is thinking.

A wrap of the day’s activity on the Australian stock market.

Given the state of the Australian economy, economists from at least two houses are forecasting a further three RBA rate cuts to 2.00% by the first quarter next year.

Downer EDI has sorted out its problems and brokers are impressed. The company is considered well placed to deal with the obstacles ahead.

A wrap of the day’s activity on the Australian stock market.